July 27, 2015

Press Release
Mitsubishi Tanabe Pharma Corporation

Organizational Restructuring
Osaka, Japan, July 27, 2015 - Mitsubishi Tanabe Pharma Corporation (President & RepresentativeDirector, CEO: Masayuki Mitsuka) announced today the following organizational restructuring.
1. Restructuring of divisions (Effective October 1, 2015)·Research Division, Development Division, Pharmacovigilance & Quality Assurance Division andPart of the functions of Sales & Marketing Division will be reorganized into the newly-established
Sohyaku. Innovative Research Division and Ikuyaku. Integrated Value Development Division.
Sohyaku. Innovative Research Division:
For the stage from basic research to the early phase of development to ensure that Proof ofConcept (POC) as rapidly as possible.
Ikuyaku. Integrated Value Development Division:
For the later phase of development after acquisition of POC and preparations for productlaunch, as well as maximization the value of a new drug after product launch.
2. Corporate Division(Effective August 1, 2015)·R&D Transformation Department will be abolished.
(Effective October 1, 2015)·Global Product Strategy Department will be abolished and its functions will be transferred toSohyaku. Innovative Research Division and Ikuyaku. Integrated Value Development Division.
·Medical Affairs Department will be abolished and its functions will be transferred to Ikuyaku.
Integrated Value Development Division.
·Medical Intelligence Department will be transferred to Ikuyaku. Integrated Value Development
Division.
·External Affairs Department will be newly established.
·CEO Office will be abolished and restructured into a group-level organization.
3. Sohyaku. Innovative Research Division (Effective October 1, 2015)·The position of Deputy Division Manager to support the Division Manager will be newly established.
· Sohyaku Strategy & Planning Department, Sohyaku Administration Department, Project Facilitation
Department, Translational Research Department, Sohyaku Quality Assurance Department,
Sohyaku Regulatory Affairs Department and Research Coordination Department will be newly
established. The functions of Research Strategy & Planning Department, Research coordination &Administration Department, Development Planning & Coordination Department, Clinical Quality
Assurance Department and Development Regulatory Affairs Department, and part of the functionsof Global Product Strategy Department will be transferred to the above newly-established divisionsand will be reorganized.
· Research Core Unit will be abolished. Chemistry Research Laboratories, Biology ResearchLaboratories, DMPK Research Laboratories and Safety Research Laboratories will be restructured
to come under the direct supervision of Sohyaku. Innovative Research Division.
·Clinical Pharmacology Department will be abolished. Its functions will be transferred to Data
Science Department and DMPK Research Laboratories.
·The department-level organizations will be transferred from Research Division and Development
Division into Sohyaku. Innovative Research Division.
1

4. Ikuyaku. Integrated Value Development Division (Effective October 1, 2015)·The position of Deputy Division Manager to support the Division Manager will be newly established.
· Ikuyaku Product Strategy Department will be newly established. Part of the functions of Global
Product Strategy Department will be transferred to Ikuyaku Product Strategy Department.
·Product Management Department and Product Coordination Department will be newly established.
·Product Marketing Department will be transferred from Sales & Marketing Division to Ikuyaku.
Integrated Value Development Division.
·Medicinal Intelligence Department will be transferred from Corporate Division to Ikuyaku. IntegratedValue Development Division.
·Medical Science Center, responsible for clarifying product profiles as well as maximizing productvalue, will be newly established. The functions of Medical Affairs Department of Corporate Division
as well as Medical Information Center of Sales & Marketing Division will be transferred to MedicalScience Center.
·Medical Affairs Department I and Medical Affairs Department II will be newly established directly
under Medical Science Center, and the functions of Medical Affairs Department will be reorganized
into the above departments. Furthermore, Ikuyaku Medical Research Department and Science
Communication Office will be newly established.
·Pharmacovigilance Center, responsible for activities relating to safety information regarding drugs indevelopment and marketed products, will be newly established. Pharmacovigilance Coordination &Administration Department, Safety Information Department, and Pharmacovigilance Department
will be transferred from Pharmacovigilance & Quality Assurance Division to come directly underPharmacovigilance Center.
· Ikuyaku Regulatory Affairs Center will be newly established. Quality Audit Department andMarketed Drug Regulatory Affairs Department will be transferred from Pharmacovigilance & Quality
Assurance Division to come directly under Ikuyaku Regulatory Affairs Center.
·PV & QA Planning and Coordination Department of Pharmacovigilance & Quality Assurance
Division will be abolished.
5. Sales & Marketing Division (Effective October 1, 2015)·Sales Human Resources Department will be newly established. Part of the functions of Strategic
Sales Planning Department will be transferred to Sales Human Resources Department.
· Primary Product Marketing Department will be newly established. Cardiovascular & Allergology
Product Marketing Department and Diabetes Product Marketing Department will be integrated intoPrimary Product Marketing Department.
6. Production Division (Effective October 1, 2015)·Production Innovation Office will be newly established to promote efficiency of production and theSCM system.
EndFor Details, Contact the Following Section
Corporate Communications Department
Tel +81-6-6205-5211 (Headquarters)
Tel +81-3-6748-7664 (Tokyo Head Office)2

Mitsubishi Tanabe Pharma Corporation Organization Chart(Effective October 1, 2015)
BranchCorporate Strategic Planning

DivisionInternal Audit

Unit

External Affairs

Department

Vaccine Business Development

Laboratories

Finance & Accounting

Center

Procurement Management

Plant

General Affairs & Human Resources

OfficeBusiness Expert

Board of Corporate Auditors

Internal Controls & Compliance
Shareholders Meeting

Board of Directors
Chairman of the Board

President

Corporate Communications
Legal Affairs & Intellectual Property

Executive Committee

Information Systems
Business Development
Sohyaku. Innovative Research

Sohyaku Strategy & Planning
Sohyaku Administration
Project Facilitation
Translational Research
Sohyaku Quality Assurance
Sohyaku Regulatory Affairs
Research Coordination
Research A
Research B
Research C
Chemistry Research
Biology Research
DMPK(*1) Research(*1) Drug Metabolism and Pharmacokinetics

Safety Research
Clinical Management
Data Science
Clinical Research I
Clinical Research II
Clinical Research III
Global Development Operations
Ikuyaku Product Strategy

Ikuyaku. Integrated Value Development

Product Management
Product Coordination
Product Marketing
Medicinal Intelligence
Medical Science

Medical Affairs I
Medical Affairs II
Ikuyaku Medical Research
Science Communication
Medical Information

Pharmacovigilance

Pharmacovigilance Coordination & Administration

Safety Information
Pharmacovigilance
Ikuyaku Regulatory Affairs

Quality Audit
Marketed Drug Regulatory Affairs

Sales & Marketing

Strategic Sales Planning
Sales Human Resources
Promotion Management
Distribution Management & Wholesalers Relations

Primary Product Marketing
Remicade
Central Nervous System Product Marketing
Product Information
Academic Research & Promotion Training
Vaccines
Business Alliance & Sales Strategy
Sales Innovation and Strategy
Hokkaido

Area Marketing

TohokuArea Marketing
Area Sales

Kitakanto

Area Marketing

Koshinetsu

Area Marketing

TokyoArea Marketing
Area Sales
Highly-intensive Hospital

Chiba

Area MarketingSaitama

Area Marketing

Yokohama

Area Marketing

Tokai

Area Marketing
Area Sales

Kyoto

Area Marketing

Osaka

Area Marketing
Area Sales

Kobe

Area Marketing

Chugoku

Area Marketing

Shikoku

Area Marketing

KyushuArea Marketing
Area Sales

Production

Production Strategy & Coordination
Supply Chain Management
Quality Management
Production Technology Management
Environment & Safety
GQP
Production Innovation

CMC(*2)CMC Strategy & Planning(*2) Chemistry, Manufacturing and Control

CMC Quality Assurance
Process Development
Pharmaceutical Research
Analytical ResearchBusiness Coordination
International Business
OTC Business
Medway Business Management